These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 21105683)
61. Computational Study of the Driving Forces and Dynamics of Curcumin Binding to Amyloid-β Protofibrils. Martin TD; Malagodi AJ; Chi EY; Evans DG J Phys Chem B; 2019 Jan; 123(3):551-560. PubMed ID: 30571122 [TBL] [Abstract][Full Text] [Related]
62. Structure of ring-shaped Aβ₄₂ oligomers determined by conformational selection. Tran L; Basdevant N; Prévost C; Ha-Duong T Sci Rep; 2016 Feb; 6():21429. PubMed ID: 26868929 [TBL] [Abstract][Full Text] [Related]
63. Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques. Poduslo JF; Curran GL; Peterson JA; McCormick DJ; Fauq AH; Khan MA; Wengenack TM Biochemistry; 2004 May; 43(20):6064-75. PubMed ID: 15147190 [TBL] [Abstract][Full Text] [Related]
64. A cyclic KLVFF-derived peptide aggregation inhibitor induces the formation of less-toxic off-pathway amyloid-β oligomers. Arai T; Sasaki D; Araya T; Sato T; Sohma Y; Kanai M Chembiochem; 2014 Nov; 15(17):2577-83. PubMed ID: 25262917 [TBL] [Abstract][Full Text] [Related]
65. Structural evolution and membrane interaction of the 40-residue β amyloid peptides: differences in the initial proximity between peptides and the membrane bilayer studied by solid-state nuclear magnetic resonance spectroscopy. Qiang W; Akinlolu RD; Nam M; Shu N Biochemistry; 2014 Dec; 53(48):7503-14. PubMed ID: 25397729 [TBL] [Abstract][Full Text] [Related]
66. X-ray crystallographic structures of trimers and higher-order oligomeric assemblies of a peptide derived from Aβ(17-36). Spencer RK; Li H; Nowick JS J Am Chem Soc; 2014 Apr; 136(15):5595-8. PubMed ID: 24669800 [TBL] [Abstract][Full Text] [Related]
67. Amyloid peptide hydrogels Wang Q; Zhou FP; Tao DD; Wei JH; Cai R; Jiang YB Chem Commun (Camb); 2023 Aug; 59(63):9599-9602. PubMed ID: 37461336 [TBL] [Abstract][Full Text] [Related]
69. Prediction of fibril formation by early-stage amyloid peptide aggregation. Hu J; Sun H; Hao H; Zheng Q J Pharm Anal; 2020 Apr; 10(2):194-199. PubMed ID: 32373391 [TBL] [Abstract][Full Text] [Related]
70. Multivalent Polymer-Peptide Conjugates-A General Platform for Inhibiting Amyloid Beta Peptide Aggregation. Jiang X; Halmes AJ; Licari G; Smith JW; Song Y; Moore EG; Chen Q; Tajkhorshid E; Rienstra CM; Moore JS ACS Macro Lett; 2019 Oct; 8(10):1365-1371. PubMed ID: 32149017 [TBL] [Abstract][Full Text] [Related]
71. How accurate are your simulations? Effects of confined aqueous volume and AMBER FF99SB and CHARMM22/CMAP force field parameters on structural ensembles of intrinsically disordered proteins: Amyloid-β Weber OC; Uversky VN Intrinsically Disord Proteins; 2017; 5(1):e1377813. PubMed ID: 30250773 [TBL] [Abstract][Full Text] [Related]
72. Peptide probes detect misfolded transthyretin oligomers in plasma of hereditary amyloidosis patients. Schonhoft JD; Monteiro C; Plate L; Eisele YS; Kelly JM; Boland D; Parker CG; Cravatt BF; Teruya S; Helmke S; Maurer M; Berk J; Sekijima Y; Novais M; Coelho T; Powers ET; Kelly JW Sci Transl Med; 2017 Sep; 9(407):. PubMed ID: 28904227 [TBL] [Abstract][Full Text] [Related]
73. SDS-PAGE analysis of Aβ oligomers is disserving research into Alzheimer´s disease: appealing for ESI-IM-MS. Pujol-Pina R; Vilaprinyó-Pascual S; Mazzucato R; Arcella A; Vilaseca M; Orozco M; Carulla N Sci Rep; 2015 Oct; 5():14809. PubMed ID: 26450154 [TBL] [Abstract][Full Text] [Related]
74. Inhibition of Beta-Amyloid Fibrillation by Luminescent Iridium(III) Complex Probes. Lu L; Zhong HJ; Wang M; Ho SL; Li HW; Leung CH; Ma DL Sci Rep; 2015 Sep; 5():14619. PubMed ID: 26419607 [TBL] [Abstract][Full Text] [Related]
75. Aβ42-binding peptoids as amyloid aggregation inhibitors and detection ligands. Luo Y; Vali S; Sun S; Chen X; Liang X; Drozhzhina T; Popugaeva E; Bezprozvanny I ACS Chem Neurosci; 2013 Jun; 4(6):952-62. PubMed ID: 23427915 [TBL] [Abstract][Full Text] [Related]
76. Facile methodology for monitoring amyloid-β fibrillization. Cook NP; Martí AA ACS Chem Neurosci; 2012 Nov; 3(11):896-9. PubMed ID: 23173070 [TBL] [Abstract][Full Text] [Related]
77. A foldamer-dendrimer conjugate neutralizes synaptotoxic β-amyloid oligomers. Fülöp L; Mándity IM; Juhász G; Szegedi V; Hetényi A; Wéber E; Bozsó Z; Simon D; Benkő M; Király Z; Martinek TA PLoS One; 2012; 7(7):e39485. PubMed ID: 22859942 [TBL] [Abstract][Full Text] [Related]
78. Insight into amyloid structure using chemical probes. Reinke AA; Gestwicki JE Chem Biol Drug Des; 2011 Jun; 77(6):399-411. PubMed ID: 21457473 [TBL] [Abstract][Full Text] [Related]
79. Chemical probes that selectively recognize the earliest Aβ oligomers in complex mixtures. Reinke AA; Ung PM; Quintero JJ; Carlson HA; Gestwicki JE J Am Chem Soc; 2010 Dec; 132(50):17655-7. PubMed ID: 21105683 [TBL] [Abstract][Full Text] [Related]
80. Insights into the aggregation mechanism of Aβ(25-40). Xiong J; JiJi RD Biophys Chem; 2017 Jan; 220():42-48. PubMed ID: 27856006 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]